MiroBio Revenue and Competitors
Estimated Revenue & Valuation
- MiroBio's estimated annual revenue is currently $3.3M per year.
- MiroBio's estimated revenue per employee is $155,000
Employee Data
- MiroBio has 21 Employees.
- MiroBio grew their employee count by -25% last year.
MiroBio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Medical Officer | Reveal Email/Phone |
2 | Senior Research Scientist | Reveal Email/Phone |
3 | Financial Controller | Reveal Email/Phone |
4 | Associate Scientist | Reveal Email/Phone |
5 | Scientist II | Reveal Email/Phone |
6 | Senior Scientist | Reveal Email/Phone |
7 | Human Resources Advisor | Reveal Email/Phone |
8 | Scientist I - Immunology | Reveal Email/Phone |
MiroBio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is MiroBio?
MiroBio is founded by leading immunologists at the University of Oxford who have spent over 15 years focussed on understanding the mechanisms which underlie T-cell signalling. The technology is based on an IP portfolio of novel antibodies with the ability to activate inhibitory co-receptors on the surface of immune cells, with a deep mechanistic understanding, MiroBio is able to optimise these antibodies to create immune-modulatory therapies which have shown remarkable efficacy in preclinical models of disease. MiroBio is now building out the team and the platform looking for strong antibody-development expertise to take the lead compounds to clinical proof-of-concept. MiroBio is a spin-out from the Oxford with an investment of £27M ($34M) from Samsara Biocapital, Oxford Sciences Innovations, Advent Life Sciences and SR One. The company is based in Oxford, retaining close links to the world-class immunology expertise and clinical trial experience within the University.
keywords:N/A
N/A
Total Funding
21
Number of Employees
$3.3M
Revenue (est)
-25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
MiroBio News
MiroBio is a biotechnology company advancing a new class of precision therapies designed to address the immune imbalance that drives autoimmune...
Other Companies in Oxford
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.5M | 21 | 5% | $5M |
#2 | $1.5M | 21 | N/A | N/A |
#3 | $1.7M | 21 | 11% | $8M |
#4 | $3.3M | 21 | 5% | N/A |
#5 | $2.1M | 21 | -12% | N/A |